Genetic aspects of cell line development from a synthetic biology perspective

Advances in Biochemical Engineering/Biotechnology

Volumn 127, Issue , 2012, Pages 251-284

  Botezatu, L ^a   Sievers, S ^a   Gama Norton, L ^a   Schucht, R ^a   Hauser, H ^a   Wirth, D ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Controlled genetic engineering; Controlled intervention; Mammalian cells; Synthetic biology; Synthetic expression cassettes

Indexed keywords

ANIMAL; ARTICLE; BIOTECHNOLOGY; CELL DIFFERENTIATION; CELL LINE; GENETICS; HUMAN; METHODOLOGY; SIGNAL TRANSDUCTION; SYNTHETIC BIOLOGY;

ANIMALS; BIOTECHNOLOGY; CELL DIFFERENTIATION; CELL LINE; HUMANS; SIGNAL TRANSDUCTION; SYNTHETIC BIOLOGY;

EID: 84874806902     PISSN: 07246145     EISSN: None     Source Type: Book Series    
DOI: 10.1007/10_2011_117     Document Type: Article

References (216)

1. Agha-Mohammadi S, O'Malley M, Etemad A, Wang Z, Xiao X, Lotze MT (2004) Secondgeneration tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med 6:817-828
2. Ailor E, Betenbaugh MJ (1998) Overexpression of a cytosolic chaperone to improve solubility and secretion of a recombinant IgG protein in insect cells. Biotechnol Bioeng 58:196-203
3. Akagi K, Kanai M, Saya H, Kozu T, Berns A (2001) A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain. Nucleic Acids Res 29:E23
4. Ali SH, DeCaprio JA (2001) Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol 11:15-23
5. Arden N, Betenbaugh MJ (2004) Life and death in mammalian cell culture: strategies for apoptosis inhibition. Trends Biotechnol 22:174-180
6. Aubel D, Fussenegger M (2010) Mammalian synthetic biology-from tools to therapies. BioEssays 32:332-345
7. Bach M, Grigat S, Pawlik B, Fork C, Utermöhlen O, Pal S, Banczyk D, Lazar A, Schömig E, Gründemann D (2007) Fast set-up of doxycycline-inducible protein expression in human cell lines with a single plasmid based on Epstein-Barr virus replication and the simple tetracycline repressor. FEBS J 274:783-790
8. Banaszynski LA, Sellmyer MA, Contag CH, Wandless TJ, Thorne SH (2008) Chemical control of protein stability and function in living mice. Nat Med 14:1123-1127
9. Baron U, Freundlieb S, Gossen M, Bujard H (1995) Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23:3605-3606
10. Baron U, Gossen M, Bujard H (1997) Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 25:2723-2729
11. Barquinero J, Eixarch H, Pérez-Melgosa M (2004) Retroviral vectors: new applications for an old tool. Gene Ther 11:S3-S9
12. Becker E, Florin L, Pfizenmaier K, Kaufmann H (2008) An XBP-1 dependent bottle-neck in production of IgG subtype antibodies in chemically defined serum-free Chinese hamster ovary (CHO) fed-batch processes. J Biotechnol 135:217-223
13. Becskei A, Serrano L (2000) Engineering stability in gene networks by autoregulation. Nature 405:590-593
14. Berens C, Hillen W (2003) Gene regulation by tetracyclines: constraints of resistance regulation in bacteria shape TetR for application in eukaryotes. Eur J Biochem 270:3109-3121
15. Bi JX, Shuttleworth J, Al-Rubeai M (2004) Uncoupling of cell growth and proliferation results in enhancement of productivity in p21CIP1-arrested CHO cells. Biotechnol Bioeng 85:741-749
16. Binley K, Iqball S, Kingsman A, Kingsman S, Naylor S (1999) An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer. Gene Ther 6:1721-1727
17. Blesch A (2004) Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Methods 33:164-172
18. Bode J, Benham C, Knopp A, Mielke C (2000) Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit Rev Eukaryot Gene Expr 10:73-90
19. Bollati-Fogolin M, Forno G, Nimtz M, Conradt HS, Etcheverrigaray M, Kratje R (2005) Temperature reduction in cultures of hGM-CSF-expressing CHO cells: effect on productivity and product quality. Biotechnol Prog 21:17-21
20. Boorsma M, Nieba L, Koller D, Bachmann MF, Bailey JE, Renner WA (2000) A temperature-regulated replicon-based DNA expression system. Nat Biotechnol 18:429-432
21. Boorsma M, Hoenke S, Marrero A, Fischer R, Bailey JE, Renner WA, Bachmann MF (2002) Bioprocess applications of a Sindbis virus-based temperature-inducible expression system. Biotechnol Bioeng 79:602-609
22. Bornkamm GW, Berens C, Kuklik-Roos C, Bechet JM, Laux G, Bachl J, Korndoerfer M, Schlee M, Hölzel M, Malamoussi A, Chapman RD, Nimmerjahn F, Mautner J, Hillen W, Bujard H, Feuillard J (2005) Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res 33:1-11
23. Borth N, Mattanovich D, Kunert R, Katinger H (2005) Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line. Biotechnol Prog 21:106-111
24. Braselmann S, Graninger P, Busslinger M (1993) A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc Natl Acad Sci U S A 90:1657-1661
25. Büning H, Nicklin SA, Perabo L, Hallek M, Baker AH (2003) AAV-based gene transfer. Curr Opin Mol Ther 5:367-375
26. Burcin MM, O'Malley BW, Tsai SY (1998) A regulatory system for target gene expression. Front Biosci J Virtual Library 3:c1-c7
27. Carvalhal AV, Moreira JL, Carrondo MJ (2001) Strategies to modulate BHK cell proliferation by the regulation of IRF-1 expression. J Biotechnol 92:47-59
28. Carvalhal AV, Marcelino I, Carrondo MJ (2003) Metabolic changes during cell growth inhibition by p27 overexpression. Appl Microbiol Biotechnol 63:164-173
29. Cho SY, Lee JH, Bae HD, Jeong EM, Jang GY, Kim CW, Shin DM, Jeon JH, Kim IG (2010) Transglutaminase 2 inhibits apoptosis induced by calcium overload through downregulation of Bax. Exp Mol Med 42:639-650
30. Chung JY, Lim SW, Hong YJ, Hwang SO, Lee GM (2004) Effect of doxycycline-regulated calnexin and calreticulin expression on specific thrombopoietin productivity of recombinant Chinese hamster ovary cells. Biotechnol Bioeng 85:539-546
31. Danke C, G€runz X, Wittmann J, Schmidt A, Agha-Mohammadi S, Kutsch O, Jäck HM, Hillen W, Berens C (2010) Adjusting transgene expression levels in lymphocytes with a set of inducible promoters. J Gene Med 12:501-515
32. Davey RE, Onishi K, Mahdavi A, Zandstra PW (2007) LIF-mediated control of embryonic stem cell self-renewal emerges due to an autoregulatory loop. FASEB J 21:2020-2032
33. Deans TL, Cantor CR, Collins JJ (2007) A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells. Cell 130:363-372
34. Deuschle U, Meyer WKH, Thiesen HJ (1995) Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 15:1907-1914
35. deZengotita VM, Schmelzer AE, Miller WM (2002) Characterization of hybridoma cell responses to elevated pCO(2) and osmolality: intracellular pH, cell size, apoptosis, and metabolism. Biotechnol Bioeng 77:369-380
36. Dorai H, Ellis D, Keung YS, Campbell M, Zhuang M, Lin C, Betenbaugh MJ (2010) Combining high-throughput screening of caspase activity with anti-apoptosis genes for development of robust CHO production cell lines. Biotechnol Prog 26:1367-1381
37. Ehrhardt A, Haase R, Schepers A, Deutsch MJ, Lipps HJ, Baiker A (2008) Episomal vectors for gene therapy. Curr Gene Ther 8:147-161
38. Eilers M, Picard D, Yamamoto KR, Bishop JM (1989) Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66-68
39. Ellgaard L, Helenius A (2003) Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4:181-191
40. Elowitz MB, Leibler S (2000) A synthetic oscillatory network of transcriptional regulators. Nature 403:335-338
41. Ertel A, Tozeren A (2008) Human and mouse switch-like genes share common transcriptional regulatory mechanisms for bimodality. BMC Genomics 9:628
42. Feil R, Wagner J, Metzger D, Chambon P (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237: 752-757
43. Fiore M, Zanier R, Degrassi F (2002) Reversible G(1) arrest by dimethyl sulfoxide as a new method to synchronize Chinese hamster cells. Mutagenesis 17:419-424
44. Florin L, Pegel A, Becker E, Hausser A, Olayioye MA, Kaufmann H (2009) Heterologous expression of the lipid transfer protein CERT increases therapeutic protein productivity of mammalian cells. J Biotechnol 141:84-90
45. Forster K, Helbl V, Lederer T, Urlinger S, Wittenburg N, Hillen W (1999) Tetracyclineinducible expression systems with reduced basal activity in mammalian cells. Nucleic Acids Res 27:708-710
46. Fox SR, Patel UA, Yap MG, Wang DI (2004) Maximizing interferon-gamma production by Chinese hamster ovary cells through temperature shift optimization: experimental and modeling. Biotechnol Bioeng 85:177-184
47. Fox SR, Tan HK, Tan MC, Wong SC, Yap MG, Wang DI (2005) A detailed understanding of the enhanced hypothermic productivity of interferon-gamma by Chinese-hamster ovary cells. Biotechnol Appl Biochem 41:255-264
48. Fraser MJ, Ciszczon T, Elick T, Bauser C (1996) Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Mol Biol 5:141-151
49. Freundlieb S, Schirra-Müller C, Bujard H (1999) A tetracycline controlled activation/ repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1:4-12
50. Fussenegger M (2001) The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog 17:1-51
51. Fussenegger M, Mazur X, Bailey JE (1997) A novel cytostatic process enhances the productivity of Chinese hamster ovary cells. Biotechnol Bioeng 55:927-939
52. Fussenegger M, Mazur X, Bailey JE (1998a) pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells. Biotechnol Bioeng 57:1-10
53. Fussenegger M, Schlatter S, Datwyler D, Mazur X, Bailey JE (1998b) Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 16:468-472
54. Gama-Norton L, Riemer P, Sandhu U, Nehlsen K, Schucht R, Hauser H, Wirth D (2009) Defeating randomness-targeted integration as a boost for biotechnology. In: Al-Rubeai M (ed) Cell engineering. Springer, London
55. Gama-Norton L, Herrmann S, Schucht R, Coroadinha AS, Low R, Alves PM, Bartholomae CC, Schmidt M, Baum C, Schambach A, Hauser H, Wirth D (2010) Retroviral vector performance in defined chromosomal loci of modular packaging cell lines. Hum Gene Ther 21:979-991
56. Geserick C, Bonarius HP, Kongerslev L, Hauser H, Mueller PP (2000) Enhanced productivity during controlled proliferation of BHK cells in continuously perfused bioreactors. Biotechnol Bioeng 69:266-274
57. Ghani K, Cottin S, Kamen A, Caruso M (2007) Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media. Gene Ther 14:1705-1711
58. Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang RY, Algire MA, Benders GA, Montague MG, Ma L, Moodie MM, Merryman C, Vashee S, Krishnakumar R, Assad-Garcia N, Andrews-Pfannkoch C, Denisova EA, Young L, Qi ZQ, Segall-Shapiro TH, Calvey CH, Parmar PP, Hutchison CA III, Smith HO, Venter JC (2010) Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329:52-56
59. Gill G, Ptashne M (1988) Negative effect of the transcriptional activator GAL4. Nature 334:721-724
60. Gitzinger M, Kemmer C, El-Baba MD, Weber W, Fussenegger M (2009) Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin. Proc Natl Acad Sci U S A 106:10638-10643
61. Glaß M, Busche A, Wagner K, Messerle M, Borst EM (2009) Conditional and reversible disruption of essential herpesvirus proteins. Nat Methods 6:577-579
62. Go WY, Ho SN (2002) Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems. J Gene Med 4:258-270
63. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89:5547-5551
64. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769
65. Greber D, Fussenegger M (2007) Mammalian synthetic biology: engineering of sophisticated gene networks. J Biotechnol 130:329-345
66. Hampf M, Gossen M (2007) Promoter crosstalk effects on gene expression. J Mol Biol 365:911-920
67. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426:803-809
68. Hartenbach S, Daoud-El Baba M, Weber W, Fussenegger M (2007) An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice. Nucleic Acids Res 35:e136
69. Hayter PM, Curling EM, Baines AJ, Jenkins N, Salmon I, Strange PG, Bull AT (1991) Chinese hamster ovary cell growth and interferon production kinetics in stirred batch culture. Appl Microbiol Biotechnol 34:559-564
70. Heinz N, Schambach A, Galla M, Maetzig T, Baum C, Loew R, Schiedlmeier B (2010) Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic range. Hum Gene Ther 22:166-176
71. Hendrick V, Winnepenninckx P, Abdelkafi C, Vandeputte O, Cherlet M, Marique T, Renemann G, Loa A, Kretzmer G, Werenne J (2001) Increased productivity of recombinant tissular plasminogen activator (t-PA) by butyrate and shift of temperature: a cell cycle phases analysis. Cytotechnology 36:71-83
72. Hofmann A, Nolan GP, Blau HM (1996) Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci U S A 93:5185-5190
73. Hu MC, Davidson N (1987) The inducible lac operator-repressor system is functional in mammalian cells. Cell 48:555-566
74. Hunter NL, Awatramani RB, Farley FW, Dymecki SM (2005) Ligand-activated Flpe for temporally regulated gene modifications. Genesis 41:99-109
75. Ibarra N, Watanabe S, Bi JX, Shuttleworth J, Al-Rubeai M (2003) Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells. Biotechnol Prog 19:224-228
76. Ito K, Ueda Y, Kokubun M, Urabe M, Inaba T, Mano H, Hamada H, Kitamura T, Mizoguchi H, Sakata T, Hasegawa M, Ozawa K (1997) Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells. Blood 90:3884-3892
77. Ivics Z, Hackett PB, Plasterk RH, Izsvák Z (1997) Molecular reconstruction of sleeping beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91:501-510
78. Izsvák Z, Chuah MKL, VandenDriessche T, Ivics Z (2009) Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors. Methods 49:287-297
79. Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, Larsen L, Kioussis D (1991) Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A 88:5096-5100
80. Jenkins N, Meleady P, Tyther R, Murphy L (2009) Strategies for analysing and improving the expression and quality of recombinant proteins made in mammalian cells. Biotechnol Appl Biochem 53:73-83
81. Kaufmann H, Mazur X, Fussenegger M, Bailey JE (1999) Influence of low temperature on productivity, proteome and protein phosphorylation ofCHOcells. BiotechnolBioeng 63:573-582
82. Kellendonk C, Tronche F, Monaghan AP, Angrand PO, Stewart F, Schutz G (1996) Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res 24:1404-1411
83. Kemmer C, Gitzinger M, Daoud-El Baba M, Djonov V, Stelling J, Fussenegger M (2010) Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat Biotechnol 28:355-360
84. Kiel C, Yus E, Serrano L (2010) Engineering signal transduction pathways. Cell 140:33-47
85. Kirchhoff S, Schaper F, Hauser H (1993) Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res 21:2881-2889
86. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88
87. Klug A. (2010) The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem 79:213-231
88. Koga A, Suzuki M, Inagaki H, Bessho Y, Hori H (1996) Transposable element in fish [11]. Nature 383:30
89. Köster M, Kirchhoff S, Schaper F, Hauser H (1995) Proliferation control of mammalian cells by the tumor suppressor IRF-1. Cytotechnology18:67-75
90. Kramer BP, Fussenegger M (2005) Hysteresis in a synthetic mammalian gene network. Proc Natl Acad Sci U S A 102:9517-9522
91. Kramer BP, Weber W, Fussenegger M (2003) Artificial regulatory networks and cascades for discrete multilevel transgene control in mammalian cells. Biotechnol Bioeng 83:810-820
92. Kramer BP, Viretta AU, Baba MDE, Aubel D, Weber W, Fussenegger M (2004) An engineered epigenetic transgene switch in mammalian cells. Nat Biotechnol 22:867-870
93. Kramer BP, Fischer M, Fussenegger M (2005) Semi-synthetic mammalian gene regulatory networks. Metab Eng 7:241-250
94. Kraunus J, Schaumann DH, Meyer J, Modlich U, Fehse B, Brandenburg G, von Laer D, Klump H, Schambach A, Bohne J, Baum C (2004) Self-inactivating retroviral vectors with improved RNA processing. Gene Ther 11:1568-1578
95. Kroger A, Koster M, Schroeder K, Hauser H, Mueller PP (2002) Activities of IRF-1. J Interferon Cytokine Res 22:5-14
96. Kühnel F, Fritsch C, Krause S, Mundt B, Wirth T, Paul Y, Malek NP, Zender L, Manns MP, Kubicka S (2004) Doxycycline regulation in a single retroviral vector by an autoregulatory loop facilitates controlled gene expression in liver cells. Nucleic Acids Res 32:e30
97. Kume A, Koremoto M, Xu R, Okada T, Mizukami H, Hanazono Y, Hasegawa M, Ozawa K (2003) In vivo expansion of transduced murine hematopoietic cells with a selective amplifier gene. J Gene Med 5:175-181
98. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, Fidler IJ (2003) Tissuespecific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res 63:2971-2976
99. Langley RR, Fan D, Guo L, Zhang C, Lin Q, Brantley EC, McCarty JH, Fidler IJ (2009) Generation of an immortalized astrocyte cell line from H-2Kb-tsA58 mice to study the role of astrocytes in brain metastasis. Int J Oncol 35:665-672
100. Levskaya A, Weiner OD, Lim WA, Voigt CA (2009) Spatiotemporal control of cell signalling using a light-switchable protein interaction. Nature 461:997-1001
101. Li Q, Peterson KR, Fang X, Stamatoyannopoulos G (2002) Locus control regions. Blood 100:3077-3086
102. Lim SF, Chuan KH, Liu S, Loh SO, Chung BY, Ong CC, Song Z (2006) RNAi suppression of Bax and Bak enhances viability in fed-batch cultures of CHO cells. Metab Eng 8: 509-522
103. Liu C, Chu I, Hwang S (2001) Pentanoic acid, a novel protein synthesis stimulant for Chinese hamster ovary (CHO) cells. J Biosci Bioeng 91:71-75
104. Lloyd DR, Holmes P, Jackson LP, Emery AN, Al-Rubeai M (2000) Relationship between cell size, cell cycle and specific recombinant protein productivity. Cytotechnology 34:59-70
105. Loew R, Vigna E, Lindemann D, Naldini L, Bujard H (2006) Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activities. J Mol Genet Med 2:107-118
106. Loew R, Meyer Y, Kuehlcke K, Gama-Norton L, Wirth D, Hauser H, Stein S, Grez M, Thornhill S, Thrasher A, Baum C, Schambach A (2010) A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration. Gene Ther 17:272-280
107. Logie C, Stewart AF (1995) Ligand-regulated site-specific recombination. Proc Natl Acad Sci U S A 92:5940-5944
108. Lufino MMP, Edser PAH, Wade-Martins R (2008) Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression. Mol Ther 16:1525-1538
109. Major MB, Camp ND, Berndt JD, Yi X, Goldenberg SJ, Hubbert C, Biechele TL, Gingras AC, Zheng N, Maccoss MJ, Angers S, Moon RT (2007) Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316:1043-1046
110. Malphettes L, Fussenegger M (2006) Improved transgene expression fine-tuning in mammalian cells using a novel transcription-translation network. J Biotechnol 124:732-746
111. Malphettes L, Weber CC, El-Baba MD, Schoenmakers RG, Aubel D, Weber W, Fussenegger M (2005) A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1. Nucleic Acids Res 33:e107
112. Margolin JF, Friedman JR, Meyer WKH, Vissing H, Thiesen HJ, Rauscher Iii FJ (1994) Kruppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci U S A 91:4509-4513
113. Markusic D, Seppen J (2010) Doxycycline regulated lentiviral vectors. Meth Mol Biol 614:69-76
114. Markusic D, Oude-Elferink R, Das AT, Berkhout B, Seppen J (2005) Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res 33:e63
115. Mátrai J, Chuah MK, Vandendriessche T (2010) Recent advances in lentiviral vector development and applications. Mol Ther 18:477-490
116. May T, Hauser H, Wirth D (2004a) Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. Nucleic Acids Res 32:5529-5538
117. May T, Lindenmaier W, Wirth D, Mueller PP (2004b) Application of a reversible immortalization system for the generation of proliferation-controlled cell lines. Cytotechnology 46:69-78
118. May T, Mueller PP, Weich H, Froese N, Deutsch U, Wirth D, Kroger A, Hauser H (2005) Establishment of murine cell lines by constitutive and conditional immortalization. J Biotechnol 120:99-110
119. May T, Hauser H, Wirth D (2006) Current status of transcriptional regulation systems. Cytotechnology 50:109-119
120. May T, Eccleston L, Herrmann S, Hauser H, Goncalves J, Wirth D (2008) Bimodal and hysteretic expression in mammalian cells from a synthetic gene circuit. PLoS One 3:e2372
121. May T, Butueva M, Bantner S, Marcusic D, Seppen J, Weich H, Hauser H, Wirth D (2010) Synthetic gene regulation circuits for control of cell expansion. Tissue Eng Part A 16: 441-452
122. Mazur X, Fussenegger M, Renner WA, Bailey JE (1998) Higher productivity of growtharrested Chinese hamster ovary cells expressing the cyclin-dependent kinase inhibitor p27. Biotechnol Prog 14:705-713
123. Mezhir JJ, Smith KD, Posner MC, Senzer N, Yamini B, Kufe DW, Weichselbaum RR (2006) Ionizing radiation: a genetic switch for cancer therapy. Cancer Gene Ther 13:1-6
124. Miller AD (2001) Production of retroviral vectors. Curr Protoc Hum Genet Chap 12: Unit 12-15
125. Miskey C, Izsvák Z, Plasterk RH, Ivics Z (2003) The frog prince: a reconstructed transposon from Rana pipiens with high transpositional activity in vertebrate cells. Nucleic Acids Res 31:6873-6881
126. Mohan C, Park SH, Chung JY, Lee GM (2007) Effect of doxycycline-regulated protein disulfide isomerase expression on the specific productivity of recombinant CHO cells: thrombopoietin and antibody. Biotechnol Bioeng 98:611-615
127. Moosmann P, Georgiev O, Thiesen HJ, Hagmann M, Schaffner W (1997) Silencing of RNA polymerases II and III-dependent transcription by the KRAB protein domain of KOX1, a Kruppel-type zinc finger factor. Biol Chem 378:669-677
128. Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, Jat PS, Noble MD, Farmer K, Partridge TA (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutationspecific cell lines. Dev Biol 162:486-498
129. Mullick A, Xu Y, Warren R, Koutroumanis M, Guilbault C, Broussau S, Malenfant F, Bourget L, Lamoureux L, Lo R, Caron AW, Pilotte A, Massie B (2006) The cumate geneswitch: a system for regulated expression in mammalian cells. BMC Biotechnol 6:43
130. Neddermann P, Gargioli C, Muraglia E, Sambucini S, Bonelli F, De Francesco R, Cortese R (2003) A novel, inducible, eukaryotic gene expression system based on the quorum-sensing transcription factor TraR. EMBO Rep 4:159-165
131. Nehlsen K, Schucht R, da Gama-Norton L, Kromer W, Baer A, Cayli A, Hauser H, Wirth D (2009) Recombinant protein expression by targeting pre-selected chromosomal loci. BMC Biotechnol 9:100
132. Ngan ESW, Schillinger K, DeMayo F, Tsai SY (2002) The mifepristone-inducible gene regulatory system in mouse models of disease and gene therapy. Semin Cell Dev Biol 13:143-149
133. Nishimura K, Fukagawa T, Takisawa H, Kakimoto T, Kanemaki M (2009) An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nat Methods 6:917-922
134. No D, Yao TP, Evans RM (1996) Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A 93:3346-3351
135. Nordstrom JL (2002) Antiprogestin-controllable transgene regulation in vivo. Curr Opin Biotechnol 13:453-458
136. Palais G, Cat AND, Friedman H, Panek-Huet N, Millet A, Tronche F, Gellen B, Mercadier JJ, Peterson A, Jaisser F (2009) Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system. Physiol Genom 37:140-146
137. Pamment J, Ramsay E, Kelleher M, Dornan D, Ball KL (2002) Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene 21:7776-7785
138. Pathak A, Patnaik S, Gupta KC (2009) Recent trends in non-viral vector-mediated gene delivery. Biotechnol J 4:1559-1572
139. Perani A, Singh RP, Chauhan R, Al-Rubeai M (1998) Variable functions of bcl-2 in mediating bioreactor stress-induced apoptosis in hybridoma cells. Cytotechnology 28: 177-188
140. Picard D (1994) Regulation of protein function through expression of chimaeric proteins. Curr Opin Biotechnol 5:511-515
141. Pichon C, Billiet L, Midoux P (2010) Chemical vectors for gene delivery: uptake and intracellular trafficking. Curr Opin Biotechnol 21:640-645
142. Pruett-Miller SM, Connelly JP, Maeder ML, Joung JK, Porteus MH (2008) Comparison of zinc finger nucleases for use in gene targeting in mammalian cells. Mol Ther 16:707-717
143. Pryciak PM (2009) Designing new cellular signaling pathways. Chem Biol 16:249-254
144. Rinaudo K, Bleris L, Maddamsetti R, Subramanian S, Weiss R, Benenson Y (2007) A universal RNAi-based logic evaluator that operates in mammalian cells. Nat Biotechnol 25:795-801
145. Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, Affabris E (2002) IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 22:39-47
146. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M, Vousden KH (1996) Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. Embo J 15:827-838
147. Rybkin II, Markham DW, Yan Z, Bassel-Duby R, Williams RS, Olson EN (2003) Conditional expression of SV40 T-antigen in mouse cardiomyocytes facilitates an inducible switch from proliferation to differentiation. J Biol Chem 278:15927-15934
148. Salmon P, Oberholzer J, Occhiodoro T, Morel P, Lou J, Trono D (2000) Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2:404-414
149. Sandhu U, Cebula M, Behme S, Riemer P, Wodarczyk C, Metzger D, Reimann J, Schirmbeck R, Hauser H, Wirth D (2010) Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells. Nucleic acids Res 39:e1
150. Sauerwald TM, Betenbaugh MJ, Oyler GA (2002) Inhibiting apoptosis in mammalian cell culture using the caspase inhibitor XIAP and deletion mutants. Biotechnol Bioeng 77:704-716
151. Sauerwald TM, Oyler GA, Betenbaugh MJ (2003) Study of caspase inhibitors for limiting death in mammalian cell culture. Biotechnol Bioeng 81:329-340
152. Sauerwald TM, Figueroa B Jr, Hardwick JM, Oyler GA, Betenbaugh MJ (2006) Combining caspase and mitochondrial dysfunction inhibitors of apoptosis to limit cell death in mammalian cell cultures. Biotechnol Bioeng 94:362-372
153. Schambach A, Galla M, Maetzig T, Loew R, Baum C (2007) Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. Mol Ther 15: 1167-1173
154. Schatz SM, Kerschbaumer RJ, Gerstenbauer G, Kral M, Dorner F, Scheiflinger F (2003) Higher expression of Fab antibody fragments in a CHO cell line at reduced temperature. Biotechnol Bioeng 84:433-438
155. Schroder M (2008) Engineering eukaryotic protein factories. Biotechnol Lett 30:187-196
156. Schroder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74:739-789
157. Schucht R, Coroadinha AS, Zanta-Boussif MA, Verhoeyen E, Carrondo MJ, Hauser H, Wirth D (2006) A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Mol Ther 14: 285-292
158. Schucht R, Wirth D, May T (2009) Precise regulation of transgene expression level and control of cell physiology. Cell Biol Toxicol 26:29-42
159. Searle PF, Stuart GW, Palmiter RD (1985) Building a metal-responsive promoter with synthetic regulatory elements. Mol Cell Biol 5:1480-1489
160. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, Zhao H, Yu X, Yang L, Tan BK, Rosenwald A, Hurt EM, Petroulakis E, Sonenberg N, Yewdell JW, Calame K, Glimcher LH, Staudt LM (2004) XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21:81-93
161. Sharma N, Moldt B, Dalsgaard T, Jensen TG, Mikkelsen JG (2008) Regulated gene insertion by steroid-induced PhiC31 integrase. Nucleic Acids Res 36:e67
162. Sibley CR, Seow Y, Wood MJ (2010) Novel RNA-based strategies for therapeutic gene silencing. Mol Ther 18:466-476
163. Siddiqui F, Li CY, Larue SM, Poulson JM, Avery PR, Pruitt AF, Zhang X, Ullrich RL, Thrall DE, Dewhirst MW, Hauck ML (2007) A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas. Mol Cancer Ther 6:380-389
164. Singh RP, Al-Rubeai M, Gregory CD, Emery AN (1994) Cell death in bioreactors: a role for apoptosis. Biotechnol Bioeng 44:720-726
165. Sinn PL, Sauter SL, McCray PB Jr (2005) Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther 12:1089-1098
166. Sipo I, Hurtado Pico A, Wang X, Eberle J, Petersen I, Weger S, Poller W, Fechner H (2006) An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy. J Mol Med 84:215-225
167. Strathdee D, Ibbotson H, Grant SGN (2006) Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PLoS ONE 1:e4
168. Sung YH, Hwang SJ, Lee GM (2005) Influence of down-regulation of caspase-3 by siRNAs on sodium-butyrate-induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin. Metab Eng 7:457-466
169. Sung YH, Lee JS, Park SH, Koo J, Lee GM (2007) Influence of co-down-regulation of caspase-3 and caspase-7 by siRNAs on sodium butyrate-induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin. Metab Eng 9:452-464
170. Sunley K, Butler M (2010) Strategies for the enhancement of recombinant protein production from mammalian cells by growth arrest. Biotechnol Adv 28:385-394
171. Sunstrom NA, Gay RD, Wong DC, Kitchen NA, DeBoer L, Gray PP (2000) Insulin-like growth factor-I and transferrin mediate growth and survival of Chinese hamster ovary cells. Biotechnol Prog 16:698-702
172. Superti-Furga G, Bergers G, Picard D, Busslinger M (1991) Hormone-dependent transcriptional regulation and cellular transformation by Fos-steroid receptor fusion proteins. Proc Natl Acad Sci U S A 88:5114-5118
173. Swinburne IA, Miguez DG, Landgraf D, Silver PA (2008) Intron length increases oscillatory periods of gene expression in animal cells. Genes Dev 22:2342-2346
174. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW, Taniguchi T (1994) Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77:829-839
175. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T (1996) Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382:816-818
176. Tascou S, Sorensen TK, Glenat V, Wang M, Lakich MM, Darteil R, Vigne E, Thuillier V (2004) Stringent rosiglitazone-dependent gene switch in muscle cells without effect on myogenic differentiation. Mol Ther 9:637-649
177. Tigges M, Marquez-Lago TT, Stelling J, Fussenegger M (2009) A tunable synthetic mammalian oscillator. Nature 457:309-312
178. Tigges M, Denervaud N, Greber D, Stelling J, Fussenegger M (2010) A synthetic low-frequency mammalian oscillator. Nucleic Acids Res 38:2702-2711
179. Toettcher JE, Mock C, Batchelor E, Loewer A, Lahav G (2010) A synthetic-natural hybrid oscillator in human cells. Proc Natl Acad Sci U S A 107:17047-17052
180. Trummer E, Fauland K, Seidinger S, Schriebl K, Lattenmayer C, Kunert R, Vorauer-Uhl K, Weik R, Borth N, Katinger H, Müller D (2006) Process parameter shifting: part II. Biphasic-a tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells. Biotechnol Bioeng 94:1045-1052
181. Unsinger J, Kröger A, Hauser H, Wirth D (2001) Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes. Mol Ther 4:484-489
182. Unsinger J, Lindenmaier W, May T, Hauser H, Wirth D (2004) Stable and strictly controlled expression of LTR-flanked autoregulated expression cassettes upon adenoviral transfer. Biochem Biophys Res Commun 319: 879-887
183. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 97:7963-7968
184. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11:636-646
185. Vegeto E, Allan GF, Schrader WT, Tsai MJ, McDonnell DP, O'Malley BW (1992) The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69:703-713
186. Volpers C, Kochanek S (2004) Adenoviral vectors for gene transfer and therapy. J Gene Med 6:S164-S171
187. Wang JD, Shi WL, Zhang GQ, Bai XM (1994) Tissue and serum levels of steroid hormones and RU 486 after administration of mifepristone. Contraception 49:245-253
188. Wang GG, Calvo KR, Pasillas MP, Sykes DB, Hacker H, Kamps MP (2006) Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat Methods 3:287-293
189. Ward M, Sattler R, Grossman IR, Bell AJ Jr, Skerrett D, Baxi L, Bank A (2003) A stable murine-based RD114 retroviral packaging line efficiently transduces human hematopoietic cells. Mol Ther 8:804-812
190. Watanabe S, Shuttleworth J, Al-Rubeai M (2002) Regulation of cell cycle and productivity in NS0 cells by the over-expression of p21CIP1. Biotechnol Bioeng 77:1-7
191. Weber W, Fussenegger M (2010) Synthetic gene networks in mammalian cells. Curr Opin Biotechnol 21:690-696
192. Weber W, Bacchus W, Daoud-El Baba M, Fussenegger M (2007) Vitamin H-regulated transgene expression in mammalian cells. Nucleic Acids Res 35:e116
193. Weber W, Marty RR, Link N, Ehrbar M, Keller B, Weber CC, Zisch AH, Heinzen C, Djonov V, Fussenegger M (2003a) Conditional human VEGF-mediated vascularization in chicken embryos using a novel temperature-inducible gene regulation (TIGR) system. Nucleic Acids Res 31:e69
194. Weber W, Schoenmakers R, Spielmann M, El-Baba MD, Folcher M, Keller B, Weber CC, Link N, van de Wetering P, Heinzen C, Jolivet B, Sequin U, Aubel D, Thompson CJ, Fussenegger M (2003b) Streptomyces-derived quorum-sensing systems engineered for adjustable transgene expression in mammalian cells and mice. Nucleic Acids Res 31:e71
195. Weber W, Lienhart C, Baba MD, Fussenegger M (2009a) A biotin-triggered genetic switch in mammalian cells and mice. Metab Eng 11:117-124
196. Weber W, Schuetz M, Denervaud N, Fussenegger M (2009b) A synthetic metabolite-based mammalian inter-cell signaling system. Mol Biosyst 5:757-763
197. Weber W, Luzi S, Karlsson M, Sanchez-Bustamante CD, Frey U, Hierlemann A, Fussenegger M (2009c) A synthetic mammalian electro-genetic transcription circuit. Nucleic Acids Res 37:e33
198. Wells DJ (2010) Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo. Cell Biol Toxicol 26:21-28
199. West AG, Fraser P (2005) Remote control of gene transcription. Hum Mol Genet 14: R101-R111
200. Wirth D, Gama-Norton L, Riemer P, Sandhu U, Schucht R, Hauser H (2007) Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol 18:411-419
201. Wong DC, Wong KT, Nissom PM, Heng CK, Yap MG (2006) Targeting early apoptotic genes in batch and fed-batch CHO cell cultures. Biotechnol Bioeng 95:350-361
202. Wong SP, Argyros O, Coutelle C, Harbottle RP (2009) Strategies for the episomal modification of cells. Curr Opin Mol Ther 11:433-441
203. Wu YI, Frey D, Lungu OI, Jaehrig A, Schlichting I, Kuhlman B, Hahn KM (2009) A genetically encoded photoactivatable Rac controls the motility of living cells. Nature 461:104-108
204. Würtele H, Little KCE, Chartrand P (2003) Illegitimate DNA integration in mammalian cells. Gene Ther 10:1791-1799
205. Yanai N, Suzuki M, Obinata M (1991) Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene. Exp Cell Res 197:50-56
206. Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC Jr, Zhou C, Liu J (2007) Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Carcinogenesis 28:174-182
207. Yao F, Svensjo T, Winkler T, Lu M, Eriksson C, Eriksson E (1998) Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther 9:1939-1950
208. Yao G, Lee TJ, Mori S, Nevins JR, You L (2008) A bistable Rb-E2F switch underlies the restriction point. Nat Cell Biol 10:476-482
209. Yazawa M, Sadaghiani AM, Hsueh B, Dolmetsch RE (2009) Induction of protein-protein interactions in live cells using light. Nat Biotechnol 27:941-945
210. Yoon SK, Kim SH, Lee GM (2003a) Effect of low culture temperature on specific productivity and transcription level of anti-4-1BB antibody in recombinant Chinese hamster ovary cells. Biotechnol Prog 19:1383-1386
211. Yoon SK, Song JY, Lee GM (2003b) Effect of low culture temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cells. Biotechnol Bioeng 82:289-298
212. Yoon SK, Hwang SO, Lee GM (2004) Enhancing effect of low culture temperature on specific antibody productivity of recombinant Chinese hamster ovary cells: clonal variation. Biotechnol Prog 20:1683-1688
213. Yoon SK, Hong JK, Choo SH, Song JY, Park HW, Lee GM (2006) Adaptation of Chinese hamster ovary cells to low culture temperature: cell growth and recombinant protein production. J Biotechnol 122:463-472
214. Yu SF, von Ruden T, Kantoff PW, Garber C, Seiberg M, Ruther U, Anderson WF, Wagner EF, Gilboa E (1986) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A 83:3194-3198
215. Zhao HF, Boyd J, Jolicoeur N, Shen SH (2003) A coumermycin/novobiocin-regulated gene expression system. Hum Gene Ther 14:1619-1629
216. Zhu Z, Ma B, Homer RJ, Zheng T, Elias JA (2001) Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem 276:25222-25229